Belite Bio (BLTE) Change in Account Payables (2022 - 2025)
Belite Bio (BLTE) posted quarterly Change in Account Payables of -$3000.0 for Q4 2025, up 62.5% year-over-year from -$1846.2 in Q4 2024, and up 62.5% quarter-over-quarter from -$8000.0 in Q4 2024.
Powered by 
Analysis
Belite Bio (BLTE) Change in Account Payables (2022 - 2025) Analysis & Trends
Belite Bio's Change in Account Payables history runs 2 years deep, the most recent figure standing at -$3000.0 for Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.87 Bn | 131.01 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.57 Bn | 77.57 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.19 Bn | 53.05 Bn | 52.00 Mn | -8.00 Mn |
| 5 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - | 5.03 Mn |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 37.53 Mn |
| 7 | Alnylam Pharmaceuticals | 35.38 Bn | 32.07 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | - |
| 10 | Belite Bio | 6.25 Bn | 6.25 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -3,000.00 |
| Dec 31, 2024 | -8,000.00 |
| Dec 31, 2022 | -41,000.00 |